Sign In
Buy IPA
$1.62
+0 (+0%)
At Close: Jan 16, 2026
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2021
08:02am, Wednesday, 28'th Jul 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeuti
IPA Stock: 7 Things to Know About Covid Vaccine Stock ImmunoPrecise as Shares Rocket 120%
02:27pm, Thursday, 22'nd Jul 2021
Today's impressive move in ImmunoPrecise's stock price has led investors in IPA stock to consider what is driving these price changes. The post IPA Stock: 7 Things to Know About Covid Vaccine Stock Im
Why ImmunoPrecise Antibodies Stock Is Soaring Today
12:49pm, Thursday, 22'nd Jul 2021
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) is surging higher Thursday after the company highlighted the ability of its antibody cocktail to potentially neutralize COVID-19 variants. ImmunoPrecise Ant
IPA Stock Increases Over 30% Pre-Market: Why It Happened
08:31am, Thursday, 22'nd Jul 2021
The stock price of ImmunoPrecise Antibodies LTD. (NASDAQ: IPA) increased by over 30% pre-market.
ImmunoPrecise's PolyTope™ TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays
08:02am, Thursday, 22'nd Jul 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) today announced new results from its TATX-03 Pol
ImmunoPrecise to Report Financial Results and Business Highlights for Fiscal Year 2021
08:08am, Thursday, 15'th Jul 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ:IPA) (TSX VENTURE:IPA) a leader in full-service, therapeutic antibody dis
ImmunoPrecise Announces Appointment of Dr. Ilse Roodink to the Role of Chief Scientific Officer and Resignation of Dr. Yasmina Abdiche
09:05pm, Wednesday, 02'nd Jun 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody d
ImmunoPrecise Moves SARS-CoV-2 PolyTope™ Cocktail Program's Path Toward IND Filing
07:28am, Thursday, 20'th May 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) (TSX venture: IPA) announces the completion of an efficacy-driven,
ImmunoPrecise Launches TATX-112 Antibody Program For Cancer, Alzheimer's Disease
11:22am, Thursday, 08'th Apr 2021
ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary Talem Therapeutics LLC has advanced developing a candidate referred to as TATX-112, against an undisclosed target, into formal lead candid
ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease
08:02am, Thursday, 08'th Apr 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody d
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter of 2021 Fiscal Year
06:48pm, Wednesday, 17'th Mar 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSX VENTURE: IPA) a leader in full-service, therapeutic antibody d
ImmunoPrecise Announces Participation at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021 (Virtual Conference)
07:28am, Thursday, 04'th Mar 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (NASDAQ: IPA) (TSXV: IPA), a leader in full-service, therapeutic antibody discove
IPA Stock Price Increases Over 10% Pre-Market: Why It Happened
08:19am, Friday, 19'th Feb 2021
The stock price of Immunoprecise Antibodies Ltd (NASDAQ: IPA) is trading at over 10% pre-market. This is why it happened.
ImmunoPrecise Announces Data from Preclinical Study of TATX-03 PolyTope™ Monoclonal Antibody Cocktail Candidate Against COVID-19
07:28am, Friday, 19'th Feb 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) (TSX Venture: IPA) announced preliminary, preclinical data in hamst
IPA Announces Closing of Over-Allotment Option Associated with the Recently Completed Bought Deal Offering of Common Shares
06:54pm, Wednesday, 10'th Feb 2021
VICTORIA, British Columbia--(BUSINESS WIRE)---- $IPA #POLYTOPE--IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA / TSX VENTURE: IPA) a leader in full-service, therapeutic an
